| Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation C Jansen, A Cox, R Schueler, M Schneider, J Lehmann, M Praktiknjo, ... Liver Transplantation 24 (1), 15-25, 2018 | 36 | 2018 |
| The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma A Cox, Y Tolkach, G Kristiansen, M Ritter, J Ellinger Clinical and Translational Oncology 22, 1524-1531, 2020 | 16 | 2020 |
| Is vesicostomy still a contemporary method of managing posterior urethral valves? A Hofmann, M Haider, A Cox, F Vauth, WH Rösch Children 9 (2), 138, 2022 | 7 | 2022 |
| Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis A Cox, Y Tolkach, J Stein, G Kristiansen, M Ritter, J Ellinger International Journal of Urology 28 (4), 424-431, 2021 | 7 | 2021 |
| Molecular urothelial tumor cell subtypes remain stable during metastatic evolution A Cox, N Klümper, J Stein, D Sikic, J Breyer, C Bolenz, F Roghmann, ... European Urology 85 (4), 328-332, 2024 | 6 | 2024 |
| Knockdown of myoferlin suppresses migration and invasion in clear-cell renal-cell carcinoma A Cox, C Zhao, Y Tolkach, D Nettersheim, D Schmidt, G Kristiansen, ... Anticancer Research 40 (6), 3119-3128, 2020 | 6 | 2020 |
| The contrasting roles of Dysferlin during tumor progression in renal cell carcinoma A Cox, C Zhao, Y Tolkach, D Nettersheim, D Schmidt, G Kristiansen, ... Urologic Oncology: Seminars and Original Investigations 38 (8), 687. e1-687. e11, 2020 | 4 | 2020 |
| Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre … B Hoeh, CC Garcia, S Banek, N Klümper, A Cox, J Ellinger, P Schmucker, ... Clinical & Translational Immunology 12 (10), e1471, 2023 | 2 | 2023 |
| High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma N Klümper, A Cox, M Eckstein, C Kuppe, M Ritter, P Brossart, J Luetkens, ... European Journal of Cancer 204, 114089, 2024 | 1 | 2024 |
| Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers M von Danwitz, N Klümper, M Bernhardt, A Cox, P Krausewitz, A Alajati, ... Cancers 15 (6), 1890, 2023 | 1 | 2023 |
| Trampolining-induced gross hematuria: Unmasking the nutcracker syndrome A Cox, A Hofmann, C Neissner, C Federle, WH Rösch Urologie (Heidelberg, Germany) 61 (10), 1110-1114, 2022 | 1 | 2022 |
| Evolution of Aquablation®—From innovation to establishment J Stein, A Cox, S Hauser, M Ritter, T Bach Turkish Journal of Urology 47 (5), 351, 2021 | 1 | 2021 |
| First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany CC Garcia, B Hoeh, S Mandal, S Banek, N Klümper, P Schmucker, ... Clinical Genitourinary Cancer, 102112, 2024 | | 2024 |
| Urology consultants versus large language models: Potentials and hazards for medical advice in urology J Eckrich, J Ellinger, A Cox, J Stein, M Ritter, A Blaikie, S Kuhn, CR Buhr BJUI compass 5 (5), 438-444, 2024 | | 2024 |
| Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center P Krausewitz, T Büttner, M von Danwitz, R Weiten, A Cox, N Klümper, ... BMC urology 24 (1), 71, 2024 | | 2024 |
| Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy T Büttner, J Ellinger, G Fechner, S Hauser, A Cox, J Stein, P Krausewitz Urology Case Reports 53, 102675, 2024 | | 2024 |
| Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer J Stein, E Krappe, A Kremer, MV Cronauer, M Essler, A Cox, N Klümper, ... Journal of Cancer Research and Clinical Oncology 150 (2), 76, 2024 | | 2024 |
| CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: An updated multicenter real … B Hoeh, C Cano Garcia, S Banek, N Klümper, A Cox, J Ellinger, ... Journal of Clinical Oncology 42 (4_suppl), 405-405, 2024 | | 2024 |
| Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma J Stein, N Klümper, P Zöhrer, T Büttner, P Krausewitz, M Ritter, ... Cureus 16 (1), 2024 | | 2024 |
| Reply to Mattias Höglund's Letter to the Editor re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During … N Klümper, A Cox, M Eckstein European urology 84 (2), e51-e52, 2023 | | 2023 |
